You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Overview

  • Product nameAnti-BACH1/BRIP1 antibodySee all BACH1/BRIP1 primary antibodies ...
  • Description
    Rabbit polyclonal to BACH1/BRIP1
  • Tested applicationsWB, IP, ICC/IF more details
  • Species reactivity
    Reacts with: Mouse, Rat, Human
  • Immunogen

    Synthetic peptide: NFKPSPSKNKGMFPGFK conjugated to KLH by a N terminal Cysteine residue linker, corresponding to amino acids 1233-1249 of Human BACH1/BRIP1

    Run BLAST with BLAST the sequence with ExPASy Run BLAST with BLAST the sequence with NCBI
  • Positive controlWhole extract of human MCF-7 cells, whole extracts of mouse NIH-3T3 and rat PC12 cells and RIPA extract of human HeLa cells.

Properties

Applications

Our Abpromise guarantee covers the use of ab49657 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
WB WB: Use a concentration of 0.1 - 1 µg/ml. Predicted molecular weight: 150 kDa.
IP IP: Use a concentration of 1 - 10 µg/ml.
ICC/IF ICC/IF: Use a concentration of 10 - 20 µg/ml.

Target

  • FunctionDNA-dependent ATPase and 5' to 3' DNA helicase required for the maintenance of chromosomal stability. Acts late in the Fanconi anemia pathway, after FANCD2 ubiquitination. Involved in the repair of DNA double-strand breaks by homologous recombination in a manner that depends on its association with BRCA1.
  • Tissue specificityUbiquitously expressed, with highest levels in testis.
  • Involvement in diseaseDefects in BRIP1 are a cause of susceptibility to breast cancer (BC) [MIM:114480]. A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case.
    Defects in BRIP1 are the cause of Fanconi anemia complementation group J (FANCJ) [MIM:609054]. It is a disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair.
  • Sequence similaritiesBelongs to the DEAD box helicase family. DEAH subfamily.
    Contains 1 helicase ATP-binding domain.
  • Domain4Fe-4S iron-sulfur-binding is required for helicase activity (PubMed:20639400).
  • Post-translational
    modifications    Phosphorylated. Phosphorylation is necessary for interaction with BRCA1, and is cell-cycle regulated.
  • Cellular localizationNucleus.

    • Target information above from: UniProt accession Q9BX63 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links
    • Alternative names
        ATP dependent RNA helicase BRIP1 antibodyATP-dependent RNA helicase BRIP1 antibodyBACH 1 antibody
        BRAC 1 Associated C Terminal Helicase 1 antibodyBRCA 1 Interacting Protein 1 antibodyBRCA1 binding helicase like protein BACH1 antibodyBRCA1 interacting protein C terminal helicase 1 antibodyBRCA1-associated C-terminal helicase 1 antibodyBRCA1-interacting protein 1 antibodyBRCA1-interacting protein C-terminal helicase 1 antibodyBRCA1/BRCA2 associated helicase 1 antibodyBRIP 1 antibodyBRIP1 antibodyFANCJ antibodyFANCJ_HUMAN antibodyFanconi anemia group J protein antibodyFLJ90232 antibodyMGC126521 antibodyMGC126523 antibodyOF antibodyProtein FACJ antibody
      see all

    References for Anti-BACH1/BRIP1 antibody (ab49657)

    ab49657 has not yet been referenced specifically in any publications.

    Publishing research using ab49657 ? Please let us know so that we can cite the reference in this datasheet

    Product Wall

    Submit an Abreview for ab49657 Submit a Question for ab49657

    There are currently no Abreviews or Questions for ab49657.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"